NHS Purchasing and Supply Agency

Purchasing for patient safety: Process Evaluation Questionnaire

Dear Colleague,

We are conducting this research to enable an evaluation of the new process relating to purchasing for patient safety. Your views are of great value to us and completion of the questionnaire shouldtake around20 minutes of your time. The research is being conducted by an independent market research agency, Exodus Researchwhich is a full member of the Market Research Society and abides strictly by its Code of Conduct. Your individual answers will not be revealed to the project team or any other individual/ organisation and will be reported collectively with all other respondents.

To complete this document electronically, please use your mouse to select the box against the answers that best meet your views or by typing in your answer.Alternatively, to complete the questionnaire manually, please print this document. Please return your completed form by06 March 2008 (information on how to return the document is provided at the end of the questionnaire). Thank you in advance for your invaluable help.

If you would like a copy of the anonymised results of this research please give your email or name postal address opposite
1. Please provide the following information
Trust
Your Department

Section 1: Overview assessment of the project

2. Please indicate how you would rate the following elements of the project. Please tick one box for each. Please write any comments in the last row
How would you rate the…. / Excellent improvement / Good improvement / Moderate improvement / Minor improvement / No change / Worsened situation
Impact that the purchasing for safety project has had on your organisation’s ability to undergo a purchasing for safety initiative in injectable medicines / 6 / 5 / 4 / 3 / 2 / 1
Workstream approach in establishing a process for purchasing for safety in your trust? / 6 / 5 / 4 / 3 / 2 / 1
Project in bringing together the key stakeholders within your organisation to address the project issues / 6 / 5 / 4 / 3 / 2 / 1
The support provided by the pilot facilitator / 6 / 5 / 4 / 3 / 2 / 1
The help received from the NHS PASA project manager / 6 / 5 / 4 / 3 / 2 / 1
Comments:
3. Please indicate how you would rate the following elements of the workstreams in establishing a process for purchasing for safety. Please tick one box for each. Please write any comments in the last row
How would you rate…. / Level of improvement….
Excellent / Good / Moderate / Minor / No change / Worsened situation / Not applicable
Developing a purchasing for safety workstream team / 6 / 5 / 4 / 3 / 2 / 1 / 0
Communicating with local purchasing / 6 / 5 / 4 / 3 / 2 / 1 / 0
Communicating with regional purchasing / 6 / 5 / 4 / 3 / 2 / 1 / 0
Communicating with national purchasing / 6 / 5 / 4 / 3 / 2 / 1 / 0
Acquiring a safer medication in use / 6 / 5 / 4 / 3 / 2 / 1 / 0
Improving usability of device / 6 / 5 / 4 / 3 / 2 / 1 / 0
Increasing staff awareness of patient safety and risk of medication errors / 6 / 5 / 4 / 3 / 2 / 1 / 0
Communicating and interacting with manufacturers / 6 / 5 / 4 / 3 / 2 / 1 / 0
Establishing requirements or specifications for purchasing / 6 / 5 / 4 / 3 / 2 / 1 / 0
Building a case in need (business case) / 6 / 5 / 4 / 3 / 2 / 1 / 0
Establishing and analysing the baseline situation in the trust / 6 / 5 / 4 / 3 / 2 / 1 / 0
Reducing risk of medication error / 6 / 5 / 4 / 3 / 2 / 1 / 0
Improving patient safety / 6 / 5 / 4 / 3 / 2 / 1 / 0
Enhancing the safety culture / 6 / 5 / 4 / 3 / 2 / 1 / 0
Evaluation the benefit and risk of implementing the workstream / 6 / 5 / 4 / 3 / 2 / 1 / 0
Comments:
4. Please indicate how helpful the following baseline assessment methods were in identifying organisational cases and areas for improvement. Please tick one box for each. Please write any comments in the last row
How would you rate the helpfulness of the…. / Very helpful / Somewhat helpful / Not very helpful / Not at all helpful / Don’t know
Workstream evaluation questionnaires (mini questionnaires) / 4 / 3 / 2 / 1 / 0
Department or discipline focus groups / 4 / 3 / 2 / 1 / 0
Procurement focus groups / 4 / 3 / 2 / 1 / 0
Baseline assessment for devices / 4 / 3 / 2 / 1 / 0
Devices purchasing questionnaire / 4 / 3 / 2 / 1 / 0
NPSA risk assessment toolkit / 4 / 3 / 2 / 1 / 0
Semi-structured interviews / 4 / 3 / 2 / 1 / 0
Comments:

Section 2 : Implementing the project

5. Please indicate how important you feel the following factors are in making the project a success. Please tick one box for each. Please write any comments in the last row
How would you rate the importance of…. / Critical / Important / Not that important / Not at all important / Don’t know / Not applicable
Good communication with the local purchasing team / 5 / 4 / 3 / 2 / 1 / 0
Good communication with the regional purchasing team / 5 / 4 / 3 / 2 / 1 / 0
Good communication with the national purchasing team / 5 / 4 / 3 / 2 / 1 / 0
Access to national databases and availability of on-line information / 5 / 4 / 3 / 2 / 1 / 0
Assessment of baseline situation / 5 / 4 / 3 / 2 / 1 / 0
Establishment of purchasing for safety project team and committee at the trust / 5 / 4 / 3 / 2 / 1 / 0
Support from senior management / 5 / 4 / 3 / 2 / 1 / 0
Support and involvement from an executive level / 5 / 4 / 3 / 2 / 1 / 0
Practice of project management skills and methods / 5 / 4 / 3 / 2 / 1 / 0
Enthusiasm and commitment to change / 5 / 4 / 3 / 2 / 1 / 0
Comments:
6. Do you think that there are any other factors that are critical in making the project successful? / No / 1
Yes (please specify below) / 2

Section 3 : Outcomes of the project

7. Please indicate the extent to which your trust or department may have benefited from the following possible outcomes as a result of participating in the purchasing for safety pilot programme. Please tick one box for each. Please write any comments in the last row
Possible benefit to trust or department…. / Significantly benefited / Somewhat benefited / Not benefited / Don’t know / Not applicable
Developing a purchasing for safety workstream team / 4 / 3 / 2 / 1 / 0
Enhancing the safety culture / 4 / 3 / 2 / 1 / 0
Building a business case / 4 / 3 / 2 / 1 / 0
Increased knowledge of risk management and patient safety issues / 4 / 3 / 2 / 1 / 0
Engaging strategic support at board level / 4 / 3 / 2 / 1 / 0
Clearer understanding of issues relating to injectable medicine and infusion device purchases, information & management / 4 / 3 / 2 / 1 / 0
Comments:
8. Do you think that there are any other project benefits to your trust or department? / No / 1
Yes (please specify below) / 2
9. Please indicate the extent to which staff may have benefited from the following possible project outcomes. Please tick one box for each. Please write any comments in the last row
Possible benefit to staff…. / Significantly benefited / Somewhat benefited / Not benefited / Don’t know / Not applicable
Improving usability of device / 4 / 3 / 2 / 1 / 0
Increased staff awareness of patient safety and risk of medication errors / 4 / 3 / 2 / 1 / 0
Communicating and interacting with manufacturers / 4 / 3 / 2 / 1 / 0
Communicating with local purchasing / 4 / 3 / 2 / 1 / 0
Communicating with regional purchasing / 4 / 3 / 2 / 1 / 0
Communicating with national purchasing / 4 / 3 / 2 / 1 / 0
Acquiring a safer medication in use / 4 / 3 / 2 / 1 / 0
Establishing requirements or specifications for purchasing / 4 / 3 / 2 / 1 / 0
Building a case in need (business case) / 4 / 3 / 2 / 1 / 0
Establishing and analysing the baseline situation in the trust / 4 / 3 / 2 / 1 / 0
Comments:
10. Do you think that there are any other project benefits to staff? / No / 1
Yes (please specify below) / 2
11. Please indicate the extent to which patients may have benefited from the following possible project outcomes. Please tick one box for each. Please write any comments in the last row
Possible benefit to patients…. / Significantly benefited / Somewhat benefited / Not benefited / Don’t know
Reducing risk of medication error / 3 / 2 / 1 / 0
Improving patient safety / 3 / 2 / 1 / 0
Comments:
12. Do you think that there are any other project benefits to patients? / No / 1
Yes (please specify below) / 2

Section 4 : Impacts of and improvements to the project

13. In your view, what is the biggest achievement for your trust or department as a consequence of the project? Please write in opposite
14. In your view, what is the biggest lesson learned from the process? Please write in opposite
15. The following is a list of possible barriers that may have been experienced when developing the project. Please indicate whether each was a barrier for you and how it was overcome. Please tick one box for each. Please write any comments in the last row
Possible barrier to developing the project…. / Not a barrier / A barrier / How barrier was overcome
Inadequate time available for the project whilst carrying on with day-to-day work / 2 / 1
Lack of support from senior managers / 2 / 1
Challenges in getting key stakeholders on board / 2 / 1
Wide scope of injectable medicines and clinical areas / 2 / 1
Poor communications with the purchasing managers / 2 / 1
Comments:
16. Did you experience any other barriers when developing the project? / No / 1
Yes (please specify below stating how overcome) / 2
17. What advice would you give to others embarking in a similar process? Please write in opposite
18. How will your trust or department build on the pilot work to continue to develop purchasing for safety? Please write in opposite
19. The following list is of possible ways in which NHS PASA might communicate the solutions to the wider NHS when they are ready for wider implementation. To what extent do you think each would be effective? Please tick one box for each. Please write any comments in the last row
Possible methods of communicating to the wider NHS…. / Very effective / Quite effective / Not effective / Don’t know
Web-based knowledge pack / 3 / 2 / 1 / 0
Articles in nursing and media press / 3 / 2 / 1 / 0
Hard copy publications or journals / 3 / 2 / 1 / 0
Website publication or journals / 3 / 2 / 1 / 0
Wide publication of a final report / 3 / 2 / 1 / 0
Participation in regional and national purchasing meetings / 3 / 2 / 1 / 0
Presentations in conferences / 3 / 2 / 1 / 0
Comments:
20. Are there any other ways that NHS PASA should communicate the solutions to the wider NHS? / No / 1
Yes (please specify below) / 2
If you would like to make any further comments on issues regarding new drug presentation and information that may affect patient safety, please write in the space opposite.

THANK YOU FOR YOUR TIME.

If completed electronically, please save your completed questionnaire as a Word document and return it by 06 March 2008 in one of the following ways. If completed manually, please post to the freepost address in (3) or fax to the number in (2) below:

  1. Send it as an attachment (otherwise the selected boxes will be deselected in transmission) to . OR
  2. Print and fax your form to 01934 750176 OR
  3. Print and free-post (no stamp required) to the following address:

Exodus Market Research Ltd

FREEPOST (SWB1735)

WESTON SUPER MARE

BS24 0ZZ

1